5 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
Follow Panic Disorder: new trials by email Literature Review of Panic Disorder trials Research Report on Panic Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of HB-1 for Panic Disorder HB-1, Telmisartan Only Product in Oral Dose Form, Verapamil Only Product in Oral Dose Form - Panic Disorder, Mental Illness | Phase 2 | Terminated | HB BioTech, LLC | 170 | 2024-10-29 | 2026-09-24 |
| A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder Darigabat, Placebo - Panic Disorder | Phase 2 | Terminated | AbbVie | 80 | 2023-07-31 | 2026-05-07 |
| Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705) Cognitive-behavioral therapy, Org 25935, Placebo - Panic Disorder | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 46 | 2008-07-23 | 2018-10-16 |
| ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment ELB139 - Panic Disorder | Phase 2 | Terminated | elbion AG | 24 | 2006-05-01 | 2006-09-29 |
| Risperidone vs. Paroxetine for Panic Attacks Risperidone, Paroxetine - Major Depressive Disorder With Panic Attacks, Panic Disorder | Phase 2 | Terminated | Beth Israel Medical Center | 90 | 2003-01-01 | 2012-10-22 |
Mental Disorders (1)
Anxiety Disorders (5) · Mental Disorders (4)
1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one (1) · Cognitive Behavioral Therapy (1) · Dosage Forms (1) · N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid (1) · Paroxetine (1) · Risperidone (1) · Telmisartan (1) · Verapamil (1)
AbbVie (1) · Beth Israel Medical Center (1) · HB BioTech, LLC (1) · Merck Sharp & Dohme LLC (1) · elbion AG (1)
United States (2) · Australia (1) · Germany (1) · Netherlands (1)
Eric Griez, Prof Dr (1) · Igor Galynker, MD, PhD (1) · Prof. Malcolm Hopwood (1)